Title: Cytokine‐based disease monitoring in refractory <scp>HLH</scp> with primary <scp>EBV</scp> infection
Abstract: Pediatrics InternationalVolume 65, Issue 1 e15590 CLINICAL NOTE Cytokine-based disease monitoring in refractory HLH with primary EBV infection Sara Konishi, Sara Konishi Department of Pediatrics, St. Luke's International Hospital, Tokyo, JapanSearch for more papers by this authorRintaro Ono, Corresponding Author Rintaro Ono [email protected] orcid.org/0000-0001-8847-2528 Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan Correspondence Rintaro Ono, Department of Pediatrics, St. Luke's International Hospital, 9-1 Akashicho, Chuo-ku, Tokyo 104-0044, Japan. Email: [email protected]Search for more papers by this authorMiyuki Tanaka, Miyuki Tanaka Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, JapanSearch for more papers by this authorKen-Ichi Imadome, Ken-Ichi Imadome Department of Advanced Medicine for Virus Infections, National Center for Child Health and Development (NCCHD), Tokyo, JapanSearch for more papers by this authorYozo Nakazawa, Yozo Nakazawa orcid.org/0000-0003-0793-815X Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, JapanSearch for more papers by this authorHirokazu Kanegane, Hirokazu Kanegane orcid.org/0000-0002-8696-9378 Department of Child Health and Development, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, JapanSearch for more papers by this authorDaisuke Hasegawa, Daisuke Hasegawa orcid.org/0000-0002-9446-9568 Department of Pediatrics, St. Luke's International Hospital, Tokyo, JapanSearch for more papers by this author Sara Konishi, Sara Konishi Department of Pediatrics, St. Luke's International Hospital, Tokyo, JapanSearch for more papers by this authorRintaro Ono, Corresponding Author Rintaro Ono [email protected] orcid.org/0000-0001-8847-2528 Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan Correspondence Rintaro Ono, Department of Pediatrics, St. Luke's International Hospital, 9-1 Akashicho, Chuo-ku, Tokyo 104-0044, Japan. Email: [email protected]Search for more papers by this authorMiyuki Tanaka, Miyuki Tanaka Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, JapanSearch for more papers by this authorKen-Ichi Imadome, Ken-Ichi Imadome Department of Advanced Medicine for Virus Infections, National Center for Child Health and Development (NCCHD), Tokyo, JapanSearch for more papers by this authorYozo Nakazawa, Yozo Nakazawa orcid.org/0000-0003-0793-815X Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, JapanSearch for more papers by this authorHirokazu Kanegane, Hirokazu Kanegane orcid.org/0000-0002-8696-9378 Department of Child Health and Development, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, JapanSearch for more papers by this authorDaisuke Hasegawa, Daisuke Hasegawa orcid.org/0000-0002-9446-9568 Department of Pediatrics, St. Luke's International Hospital, Tokyo, JapanSearch for more papers by this author First published: 24 August 2023 https://doi.org/10.1111/ped.15590Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. CONFLICT OF INTEREST STATEMENT The authors declare no conflicts of interest. Supporting Information Filename Description ped15590-sup-0001-Supinfo.docxWord 2007 document , 1.9 MB Figures S1-S2 Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. REFERENCES 1Ishii E. Hemophagocytic lymphohistiocytosis in children: pathogenesis and treatment. Front Pediatr. 2016; 4: 47. 2Wada T, Muraoka M, Yokoyama T, Toma T, Kanegane H, Yachie A. Cytokine profiles in children with primary Epstein-Barr virus infection. Pediatr Blood Cancer. 2013; 60: E46–8. 3Wada T, Kanegane H, Ohta K, Katoh F, Imamura T, Nakazawa Y, et al. Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency. Cytokine. 2014; 65: 74–8. 4Maruoka H, Inoue D, Takiuchi Y, Nagano S, Arima H, Tabata S, et al. IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome. Ann Hematol. 2014; 93: 393–401. 5Tangye SG, Al-Herz W, Bousfiha A. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020; 40: 24–64. Volume65, Issue1January/December 2023e15590 ReferencesRelatedInformation
Publication Year: 2023
Publication Date: 2023-01-01
Language: en
Type: article
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 1
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot